RIO DE JANEIRO, BRAZIL - Approved on an emergency basis in Canada and the United Kingdom, Pfizer's Covid-19 vaccine in partnership with the German biotechnology company BioNTech is trying to enter the Brazilian market through a commitment to sell 70 million doses to be delivered in 2021.
In order to be safely administered in the country, the immunizer needs to be stored at approximately -75ºC, an unfeasible level for Brazil's cooling network. The solution offered by the company to ship the item safely is a transport box containing dry ice, which can hold up to 5,000 . . .